Literature DB >> 20466732

Activation and repression of cellular immediate early genes by serum response factor cofactors.

Seung-Min Lee1, Mansi Vasishtha, Ron Prywes.   

Abstract

The induction of expression of many cellular immediate early genes (IEG) involves the transcription factor serum response factor (SRF). Two families of SRF coactivators have also been implicated in IEG induction, the ternary complex factors (TCFs), ELK1, Sap1, and Net, and the myocardin-related factors, MKL1 and MKL2. We found that serum induction of some SRF target genes is preferentially regulated by MKL1/2, whereas others are redundantly activated by both TCFs and MKL1/2. Yet ELK1 can also repress transcription. Binding of ELK1 and MKL1 to SRF has been found to be mutually exclusive in vitro, suggesting that ELK1 could repress expression of IEGs by blocking MKL1 binding. We characterized the in vivo binding of MKL1 and ELK1 to target genes and found an inverse relationship of serum-induced MKL1 binding and serum-decreased ELK1 binding. However, experiments with short hairpin RNA-mediated MKL1/2 depletion and expression of a nuclear MKL1 (N100) variant in stably transfected cells failed to alter ELK1 binding, suggesting that ELK1 binding to target genes is regulated independently of MKL1/2. Nevertheless, we found that short interfering RNA-mediated depletion of TCFs increased target gene expression in cells containing the N100 MKL1 activator, most notably in cells under continuous growth conditions. These results indicate that the TCFs can function both as activators and repressors of target gene expression depending upon the cellular growth conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466732      PMCID: PMC2903344          DOI: 10.1074/jbc.M110.108878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.

Authors:  Shen-Hsi Yang; Ellis Jaffray; Ron T Hay; Andrew D Sharrocks
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

2.  Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters.

Authors:  Tadashi Yoshida; Qiong Gan; Yueting Shang; Gary K Owens
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-20       Impact factor: 4.249

Review 3.  The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis.

Authors:  G C Teg Pipes; Esther E Creemers; Eric N Olson
Journal:  Genes Dev       Date:  2006-06-15       Impact factor: 11.361

4.  MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNA-binding domain.

Authors:  Alexia-Ileana Zaromytidou; Francesc Miralles; Richard Treisman
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.

Authors:  Jun Wang; AnKang Li; ZhiGao Wang; XinHua Feng; Eric N Olson; Robert J Schwartz
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

6.  Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.

Authors:  Susanne Muehlich; Ruigong Wang; Seung-Min Lee; Thera C Lewis; Chao Dai; Ron Prywes
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

7.  RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding.

Authors:  Sebastian Guettler; Maria K Vartiainen; Francesc Miralles; Banafshe Larijani; Richard Treisman
Journal:  Mol Cell Biol       Date:  2007-11-19       Impact factor: 4.272

8.  Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.

Authors:  Toru Tanaka; Hiroko Sato; Hiroshi Doi; Carolina A Yoshida; Takehisa Shimizu; Hiroki Matsui; Miki Yamazaki; Hideo Akiyama; Keiko Kawai-Kowase; Tatsuya Iso; Toshihisa Komori; Masashi Arai; Masahiko Kurabayashi
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

9.  Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

Authors:  Bo Cen; Ahalya Selvaraj; Rebecca C Burgess; Johann K Hitzler; Zhigui Ma; Stephan W Morris; Ron Prywes
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL.

Authors:  Maria K Vartiainen; Sebastian Guettler; Banafshe Larijani; Richard Treisman
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

View more
  44 in total

1.  Nucleoskeletal regulation of transcription: Actin on MRTF.

Authors:  Ekaterina Sidorenko; Maria K Vartiainen
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

2.  Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation.

Authors:  Scott D Varney; Courtney B Betts; Rui Zheng; Lei Wu; Boris Hinz; Jiliang Zhou; Livingston Van De Water
Journal:  J Cell Sci       Date:  2016-01-12       Impact factor: 5.285

3.  LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration.

Authors:  Qiande Hu; Chun Guo; Yali Li; Bruce J Aronow; Jinsong Zhang
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

4.  Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.

Authors:  Mark R Lundquist; Andrew J Storaska; Ting-Chun Liu; Scott D Larsen; Todd Evans; Richard R Neubig; Samie R Jaffrey
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

Review 5.  Regulation of primary response genes.

Authors:  Trent Fowler; Ranjan Sen; Ananda L Roy
Journal:  Mol Cell       Date:  2011-11-04       Impact factor: 17.970

6.  MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.

Authors:  X Cheng; Y Yang; Z Fan; L Yu; H Bai; B Zhou; X Wu; H Xu; M Fang; A Shen; Q Chen; Y Xu
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

7.  Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition.

Authors:  Zhen Sun; Anja Schwenzer; Tristan Rupp; Devadarssen Murdamoothoo; Rolando Vegliante; Olivier Lefebvre; Annick Klein; Thomas Hussenet; Gertraud Orend
Journal:  Cancer Res       Date:  2017-12-19       Impact factor: 12.701

8.  Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways.

Authors:  Lawryn H Kasper; Mary C Thomas; Gerard P Zambetti; Paul K Brindle
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

9.  Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts.

Authors:  Larry L Luchsinger; Cassandra A Patenaude; Barbara D Smith; Matthew D Layne
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

10.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.